Grange, Jean-Didier

Publishing since 1983 (Dinosaur)

Has published 104 publications in 28 years

Number of publications published per year by Grange, Jean-Didier. (Source : PubMed)

Distribution of publications types for Grange, Jean-Didier. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Rosmorduc O, Chevreau C, Dielenseger P, Ederhy S, Goldwasser F, Grange JD, Mortier L, Neidhardt-Berard ME, Robert C, Scotté F, Seitz JF. [Guidelines for treatment of hepatocellular or renal carcinoma with sorafenib]  Gastroenterol. Clin. Biol.  2010;34;3  
•  Arnault JP, Wechsler J, Escudier B, Spatz A, Tomasic G, Sibaud V, Aractingi S, Grange JD, Poirier-Colame V, Malka D, Soria JC, Mateus C, Robert C. Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.  J. Clin. Oncol.  2009;27;23  
•  Ancel D, Amiot X, Chaslin-Ferbus D, Hagege I, Garioud A, Girot R, Pol S, Grange JD. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.  Eur J Gastroenterol Hepatol  2009;21;7  
•  Montravers F, Kerrou K, Nataf V, Huchet V, Lotz JP, Ruszniewski P, Rougier P, Duron F, Bouchard P, Grangé JD, Houry S, Talbot JN. Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.  J. Clin. Endocrinol. Metab.  2009;94;4  
•  Pol J, Le Pendeven C, Beby-Defaux A, Rabut E, Jais JP, Pilloux M, Osada C, Zatla F, Assami H, Grange JD, Kremsdorf D, Nicolas JC, Soussan P. Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoring.  J. Virol. Methods  2008;154;1-2  
•  Doffoël M, Bonnetain F, Bouché O, Vetter D, Abergel A, Fratté S, Grangé JD, Stremsdoerfer N, Blanchi A, Bronowicki JP, Caroli-Bosc FX, Causse X, Masskouri F, Rougier P, Bedenne L. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).  Eur. J. Cancer  2008;44;4  
•  Rosmorduc O, Wendum D, Arrivé L, Elnaggar A, Ennibi K, Hannoun L, Charlotte F, Grangé JD, Poupon R. Phenotypic expression of ferroportin disease in a family with the N144H mutation.  Gastroenterol. Clin. Biol.  2008;32;3  
•  Talbot JN, Montravers F, Gutman F, Kerrou K, Huchet V, Grahek D, Andre T, Houry S, Touboul E, Rosmorduc O, Poupon R, Ruszniewski P, Rougier P, Grange JD. [PET and digestive cancers]  Presse Med  2008;37;2 Pt 2  
•  Marcellin P, Horsmans Y, Nevens F, Grange JD, Bronowicki JP, Vetter D, Purdy S, Garg V, Bengtsson L, McNair L, Alam J. Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.  J. Hepatol.  2007;47;4  
•  Nousbaum JB, Cadranel JF, Nahon P, Khac EN, Moreau R, Thévenot T, Silvain C, Bureau C, Nouel O, Pilette C, Paupard T, Vanbiervliet G, Oberti F, Davion T, Jouannaud V, Roche B, Bernard PH, Beaulieu S, Danne O, Thabut D, Chagneau-Derrode C, de Lédinghen V, Mathurin P, Pauwels A, Bronowicki JP, Habersetzer F, Abergel A, Audigier JC, Sapey T, Grangé JD, Tran A. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis.  Hepatology  2007;45;5  

[ See timeline ] [ See all publications ]